Mphasis Q4 FY26 Results: ₹62 Dividend, 11.6% Growth

What Mphasis reported for Q4 and FY26

Mphasis announced its financial results for the quarter and year ended March 31, 2026, alongside a set of board decisions taken at an April 29, 2026 meeting. The company reported FY26 revenue growth of 11.6% year-on-year (6.7% in constant currency), backed by what it described as AI-led initiatives. For the March quarter, it reported double-digit year-on-year revenue growth and higher profit compared with the previous quarter. Mphasis also recommended a final dividend of ₹62 per share, subject to shareholder approval. Separately, the board cleared key leadership re-appointments, including CEO and Managing Director Nitin Rakesh for another five-year term starting October 1, 2026. The company said the FY26 new total contract value (TCV) wins reached a record USD 2.1 billion, with a large share attributed to AI-led deals.

Q4 FY26 numbers: profit, revenue and margins

For the quarter ended March 31, 2026 (Q4 FY26), Mphasis reported consolidated net profit of ₹510 crore, up from ₹440 crore in the previous quarter. Revenue from operations came in at ₹4,200 crore versus ₹4,000 crore in the preceding quarter, reflecting sequential growth. On a year-on-year basis, the company reported a 14.4% revenue increase for the quarter. The company also stated that quarterly revenue grew 6.0% quarter-on-quarter, while a table in the same set of information showed revenue moving from ₹4,000 crore to ₹4,200 crore, implying 5.0% QoQ growth. EBIT for the quarter was reported at ₹650 crore, up from ₹610 crore quarter-on-quarter. EBIT margin expanded to 15.38% from 15.21% in the prior quarter, indicating a modest improvement in operating efficiency. The company reported quarterly EPS of ₹26.7.

FY26 performance: revenue growth and profitability

For the full financial year FY26, Mphasis reported consolidated revenue of ₹15,879.65 crore, up 11.6% from ₹14,229.99 crore in FY25. Annual net profit was reported at ₹1,862.60 crore, compared with ₹1,702.14 crore in the previous year. Basic earnings per share improved to ₹97.82 from ₹89.87, based on the numbers shared alongside the results. The company also disclosed EPS before exceptional items of ₹99.2 for FY26. Operating margin for the year was described as stable at 15.3%. Alongside reported growth, the company highlighted constant currency growth of 6.7% for FY26.

Deal momentum: USD 2.1 billion in FY26 TCV wins

Mphasis said it closed FY26 with record new TCV wins of USD 2.1 billion. It attributed 60% of these annual wins to AI-led deals, indicating that a majority of the year’s contracted wins were linked to AI initiatives as per the company’s classification. For the March quarter alone, Mphasis reported USD 407 million in new TCV, with 64% described as AI-led. The company positioned this mix as a reflection of customer demand for AI-led transformation, although it did not provide a sector-wise or geography-wise split in the information shared here. The emphasis on TCV and AI mix was a central element of the company’s commentary around growth drivers.

Dividend: ₹62 per share, record date and AGM timeline

The board recommended a final dividend of ₹62 per equity share (face value ₹10 each) for FY26. This dividend is subject to shareholder approval at the upcoming Annual General Meeting (AGM). The record date for dividend entitlement was stated as July 8, 2026. The 35th AGM is scheduled for July 23, 2026, and is set to be conducted through video conferencing and other audio-visual means. Mphasis also disclosed an estimated cash outflow of approximately ₹1,183.20 crore for the final dividend, based on the total payout figure provided. If approved, the company indicated that the dividend would be distributed within 30 days of the AGM.

Leadership decisions: CEO term extension and independent director

Mphasis announced the re-appointment of Mr. Nitin Rakesh as Chief Executive Officer and Managing Director for a second five-year term, effective October 1, 2026. The re-appointment is subject to shareholder approval at the AGM. The board also approved the re-appointment of Ms. Maureen Anne Erasmus as an Independent Director for a second and final term of five years, effective December 20, 2026, again subject to shareholder approval. These decisions were presented as part of the board outcomes shared alongside the audited results.

Governance and audit: board approval and auditor opinion

The company said its Board of Directors, at the April 29, 2026 meeting, approved the audited standalone and consolidated financial results for Q4 and FY26. The results were reviewed by the statutory auditors, M/s B S R & Co. LLP. The auditors provided unmodified opinions on the results, as stated in the disclosure. This matters for investors because an unmodified opinion indicates the auditors did not flag qualifications or adverse findings in their report, based on the information provided.

Investor communication: analyst call schedule

Mphasis scheduled an investor or analyst presentation for Thursday, April 30, 2026, at 8:30 AM IST in connection with the Q4 and FY26 financial results. The timing was shared as part of the company’s regulatory communication around results and board decisions. Such presentations typically help investors understand quarterly movements and business commentary beyond the headline numbers, although the content of the presentation was not included here.

Key numbers at a glance

The following table compiles the main reported figures and dates disclosed in the provided information.

Market and investor lens: what stands out in this update

From the disclosed numbers, Mphasis delivered sequential improvement in both profit and margins in Q4 FY26, alongside year-on-year revenue growth. The FY26 revenue growth of 11.6% on a reported basis, paired with 6.7% constant currency growth, provides a clearer view of performance after adjusting for currency movement. The company’s disclosures put significant weight on AI-led wins, with 60% of FY26 TCV and 64% of Q4 TCV categorized as AI-led. The ₹62 final dividend, along with a stated payout implication of about ₹1,183.20 crore, is a key shareholder-return data point and comes with clear milestones including the July 8 record date and July 23 AGM.

Conclusion

Mphasis closed FY26 with reported revenue growth of 11.6%, improved profits, and steady operating margins, while highlighting record USD 2.1 billion new TCV wins for the year. For investors, the near-term calendar includes the dividend record date on July 8, 2026, and shareholder voting at the July 23, 2026 AGM, where the final dividend and leadership re-appointments are scheduled for approval.